Cardiac Monitoring and Cardiac Rhythm Management Devices Market Size, Share, Trends, & Industry Analysis Report
By Type, By Procedure (Invasive and Non-invasive), By Application, By End User, and By Region – Market Forecast, 2025–2034
- Published Date:Aug-2025
- Pages: 129
- Format: PDF
- Report ID: PM6283
- Base Year: 2024
- Historical Data: 2020-2023
Overview
The global cardiac monitoring and cardiac rhythm management devices market size was valued at USD 21.76 billion in 2024, growing at a CAGR of 4.85% from 2025–2034. The global rise in the aging population coupled with the growing prevalence of cardiovascular diseases and arrhythmias is driving demand for cardiac monitoring and rhythm management devices.
Key Insights
- The cardiac monitoring devices segment dominated the global cardiac monitoring and cardiac rhythm management devices market share in 2024, driven by rising prevalence of cardiovascular diseases and increasing adoption of wearable and remote monitoring technologies.
- The cardiac rhythm management devices segment is projected to grow at the fastest CAGR, fueled by technological advancements in implantable devices and growing demand for minimally invasive treatment options.
- The North America cardiac monitoring and cardiac rhythm management devices market dominated the global share in 2024, driven by advanced healthcare infrastructure and high adoption of digital health solutions.
- The U.S. cardiac monitoring and cardiac rhythm management devices market accounted for the largest regional share in North America in 2024, fueled by high disease burden, increasing outpatient procedures, and strong presence of key medical device manufacturers.
- The Asia Pacific cardiac monitoring and cardiac rhythm management devices market is projected to grow at the fastest CAGR during the forecast period, driven by rising healthcare investments, expanding hospital infrastructure, and increasing awareness of early cardiac disease detection.
- The China cardiac monitoring and cardiac rhythm management devices market is expanding rapidly, fueled by large patient pool, growing government healthcare initiatives, and increasing adoption of advanced diagnostic and therapeutic devices.
Industry Dynamics
- Rising prevalence of cardiovascular diseases is increasing the demand for cardiac monitoring and rhythm management devices to ensure timely diagnosis and treatment.
- Growing aging population is contributing to higher adoption of these devices as elderly patients face greater risk of arrhythmias and heart failure.
- Technological advancements such as miniaturized implants, wireless connectivity and AI-based monitoring solutions are creating opportunities to improve treatment accuracy and patient comfort.
- High device costs along with the risks of complications during implantation, and limited access to advanced cardiac care in low and middle-income regions are restricting market adoption.
Market Statistics
- 2024 Market Size: USD 21.76 Billion
- 2034 Projected Market Size: USD 34.90 Billion
- CAGR (2025–2034): 4.85%
- North America: Largest Market Share
Cardiac monitoring and cardiac rhythm management devices are medical technologies used to diagnose, monitor, and treat heart rhythm disorders and other cardiovascular conditions. The product portfolio includes pacemakers, implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy devices, wearable monitors, and remote monitoring devices. These devices support accurate diagnosis, continuous monitoring, and timely intervention, helping healthcare providers manage arrhythmias, heart failure, and other cardiac conditions effectively. Their use in hospitals, clinics, and home care settings enhances patient outcomes and reduces the risk of complications.
In clinical practice, bio-implant devices regulate abnormal heart rhythms and prevent sudden cardiac events, while external and wearable monitors track cardiac activity for early detection of arrhythmias. Remote monitoring systems enable real-time data transmission, allowing physicians to adjust therapy promptly and reduce hospital visits. As an example, in April 2025, HeartBeam partnered with AccurKardia to integrate AccurKardia’s FDA-cleared ECG analysis software, AccurECG, into HeartBeam’s compact ECG device, making advanced cardiac monitoring more accessible beyond traditional clinical settings. This collaboration is expected to speed up product development while lowering costs and timelines. Furthermore, the adoption of advanced devices is growing as healthcare providers focus on patient safety, treatment efficiency, and cost-effective management of chronic cardiovascular diseases.
The cardiac monitoring and rhythm management devices market is expanding due to the rising prevalence of cardiovascular disorders, aging populations, and increasing awareness of preventive cardiac care. Rising technological advancements such as miniaturized devices, wireless connectivity and AI-enabled monitoring are driving market growth. Whereas, increasing government policies, rising healthcare infrastructure investments in emerging markets and growing demand for home-based and remote monitoring systems further contribute to the market expansion. In addition, the rising improvements in device safety, battery life and patient comfort are expected to sustain market growth in the coming years.
Drivers & Opportunities
Global Increase in Cardiovascular Disease Burden: The growing prevalence of cardiovascular diseases is a major driver for the cardiac monitoring and rhythm management devices market. Factors such as sedentary lifestyles, rising obesity, diabetes, and hypertension are contributing to higher incidence rates of arrhythmias and heart failure. According to the WHO, cardiovascular diseases are the leading cause of death worldwide, responsible for about 17.9 million deaths annually. Over 80% of these deaths result from heart attacks and strokes, and nearly one-third occur prematurely in people under the age of 70. This trend created strong demand for advanced diagnostic and therapeutic devices that enable continuous monitoring and timely intervention. Hospitals and clinics are adopting implantable cardioverter defibrillators, pacemakers, and wearable monitoring systems to manage the growing patient base. As the global cardiovascular disease burden rises, healthcare providers are prioritizing effective solutions to reduce mortality and improve long-term patient outcomes.
Aging Populations in Developed and Emerging Economies: The expansion of the elderly population in developed and emerging economies is significantly influencing demand for cardiac monitoring and rhythm management devices. Older adults are more prone to arrhythmias, heart failure, and other cardiac complications, which increases the need for continuous monitoring and rhythm stabilization therapies. As per the World Health Organization (WHO), one in six people worldwide will be 60 years or older by 2030. The population in this age group will increase from 1 billion in 2020 to 1.4 billion, and is projected to reach 2.1 billion by 2050. The number of people aged 80 and above will triple to 426 million by 2050. The aging demographic is also associated with higher hospital admissions, driving healthcare systems to adopt cost-effective and efficient technologies. Pacemakers, cardiac resynchronization therapy devices, and remote monitoring solutions are rapidly deployed to address age-related cardiac conditions. The rising geriatric base is expected to remain a key growth factor supporting long-term market expansion globally.
Segmental Insights
Type Analysis
Based on type, the segmentation includes cardiac monitoring devices and cardiac rhythm management devices. The cardiac monitoring devices segment dominated the market in 2024, driven by rising adoption of wearable ECGs, Holter monitors and remote monitoring systems for early arrhythmia detection. These devices support timely diagnosis and reduce hospital admissions. Moreover, growing demand for home-based monitoring solutions and advancements in wireless connectivity are strengthening the market presence of this segment, as healthcare providers prioritize preventive care and long-term disease management.
The cardiac rhythm management devices segment is projected to grow at the fastest CAGR during the forecast period, due to rising demand for pacemakers, implantable cardioverter defibrillators, and cardiac resynchronization therapy devices. For instance, in May 2025, the FDA approved Element Science’s Jewel Patch, an AI-enabled wearable defibrillator for sudden cardiac arrest patients. The patch is water-resistant, worn for up to a week without maintenance and transmits real-time data to doctors. Its AI reduces false alarms, improving patient safety and care efficiency. These devices are essential for managing heart failure and arrhythmias in aging populations. Also, continuous innovations in miniaturization and battery longevity are supporting wider adoption, while expanding healthcare infrastructure in emerging economies further boosts demand.
Procedure Analysis
Based on procedure, the segmentation includes invasive and non-invasive. The invasive segment dominated the market in 2024, driven by strong adoption of pacemakers, ICDs, and CRT devices that require surgical implantation. These devices provide effective rhythm regulation and are preferred in patients with severe cardiac complications. Moreover, rising prevalence of advanced arrhythmias and heart failure is increasing procedure volumes. In addition, improvements in surgical techniques and post-operative care are enhancing patient outcomes, supporting the dominance of invasive procedures.
The non-invasive segment is projected to grow at the fastest CAGR during the forecast period, due to rising demand for external cardiac monitors and wearable devices. Non-invasive monitoring offers convenience and reduces patient risks compared to surgical options. Also, the expansion of telemedicine services supports adoption of remote ECGs and continuous monitoring systems. In addition, growing preference for preventive healthcare and cost-effective solutions strengthens the outlook for this segment.
Application Analysis
Based on application, the segmentation includes arrhythmias, myocardial infarction, heart failure and other applications. The arrhythmias segment dominated the market in 2024, fueled by high prevalence of atrial fibrillation and ventricular tachycardia worldwide. These conditions require consistent monitoring and rhythm management to prevent complications. Moreover, growing adoption of implantable and wearable devices enables continuous detection of irregular heartbeats. In addition, awareness campaigns and clinical guidelines promoting early intervention have strengthened the market demand for arrhythmia-focused monitoring and therapeutic devices across hospitals and clinics.
The heart failure segment is projected to grow at the fastest CAGR during the forecast period, due to rising incidence of chronic heart failure among elderly populations. Cardiac resynchronization therapy devices are widely used for improving cardiac function and reducing hospitalization. Moreover, growing investments in clinical research are enhancing device effectiveness. In addition, expanding home healthcare and remote monitoring solutions are further driving the adoption of devices for heart failure management.
End User Analysis
Based on end user, the segmentation includes hospitals & clinics, ambulatory surgery centers, and other end users. The hospitals & clinics segment dominated the market in 2024, driven by high patient inflow, availability of advanced infrastructure, and access to skilled cardiologists. Hospitals remain primary centers for device implantation and monitoring procedures. Moreover, continuous investments in cardiac care units support large-scale adoption. In addition, favorable reimbursement frameworks in developed countries further enhance device utilization, solidifying hospitals and clinics as the leading end user segment globally.
The ambulatory surgery centers segment is projected to grow at the fastest CAGR during the forecast period, due to increasing preference for outpatient procedures and minimally invasive surgeries. These centers provide cost-effective treatment and shorter recovery times compared to hospitals. Moreover, advancements in implantable device technologies are supporting their adoption in outpatient settings. In addition, healthcare cost containment initiatives in several countries further strengthen demand for this segment.
Regional Analysis
North America cardiac monitoring and cardiac rhythm management devices market dominated the global market in 2024. This is due to the high prevalence of cardiovascular diseases in the U.S., which continues to accelerate the need for implantable cardioverter defibrillators, pacemakers, and remote monitoring systems. The region benefits from advanced healthcare facilities, strong clinical adoption, and favorable reimbursement frameworks that fuels the use of high-cost technologies. Moreover, rapid product innovations, integration of AI-based monitoring tools and rising awareness of preventive care support ongoing adoption is propelling North America’s leadership position in the global market.
The U.S. Cardiac Monitoring and Cardiac Rhythm Management Devices Market Insight
The U.S. held a largest market share in the North America cardiac monitoring and cardiac rhythm management devices landscape in 2024, driven by the rising prevalence of atrial fibrillation, heart failure and sudden cardiac arrest, which fuels demand for implantable rhythm management devices and advanced cardiac monitors. The presence of leading medical device manufacturers and continuous R&D investment is shaping innovation in wireless and AI-enabled monitoring systems. In October 2023, InfoBionic received FDA 510(k) clearance for its next-generation remote ECG monitoring device, which uses a Bluetooth six-lead sensor for patients needing cardiac monitoring. Moreover, supportive reimbursement policies, high healthcare expenditure and integration of telehealth services are boosting adoption of home-based monitoring solutions, positioning the U.S. as a critical growth engine for the overall global market.
Europe Cardiac Monitoring and Cardiac Rhythm Management Devices Market
The cardiac monitoring and cardiac rhythm management devices landscape in Europe is projected to hold a substantial share in 2034. This is owing to the rising burden of arrhythmias and heart failure among its elderly population, particularly across Germany, France, and Italy. According to the European Commission, the EU records over 6 million new cases of cardiovascular disease and more than 1.8 million related deaths annually, resulting in an economic burden exceeding USD 245.5 billion each year. Also, the strong healthcare systems, focus on preventive cardiology, and widespread use of pacemakers and implantable defibrillators are enhancing demand. Furthermore, ongoing innovation in AI-driven diagnostics and remote monitoring platforms is improving treatment outcomes. In addition, favorable reimbursement mechanisms and European Union initiatives supporting digital health adoption are helping accelerate uptake of cardiac monitoring and rhythm management devices in this region.
Asia Pacific Cardiac Monitoring and Cardiac Rhythm Management Devices Market
The market in Asia Pacific is projected to grow at the fastest CAGR during the forecast period. This growth is expanding driven by rapid growth in the aging population across China, Japan, and India, which increases the demand for arrhythmia management devices. Expanding hospital infrastructure, rising healthcare investments, and the adoption of digital health technologies are further boosting demand for wearable and remote monitoring solutions. In addition, government-backed initiatives to improve access to cardiovascular care and cost-effective device innovations are making advanced monitoring solutions more accessible across urban and rural areas in this region.
China Cardiac Monitoring and Cardiac Rhythm Management Devices Market Overview
The market in China is expanding due to rapid urbanization, higher cardiovascular disease incidence and a growing elderly population, all of which create strong demand for cardiac monitoring and rhythm management devices. According to a 2023 report by the Ministry of Civil Affairs and the China National Committee on Ageing, there were 216.76 million people aged 65 and above in China, making up 15.4% of the total population. Moreover, rapidly expanding cardiology departments, increasing hospital investments and government focus on modernizing healthcare infrastructure are boosting adoption rates. In addition, rising awareness of preventive healthcare and advancements in local medical device manufacturing are making implantable and wearable monitoring solutions more affordable.
Key Players & Competitive Analysis Report
The cardiac monitoring and cardiac rhythm management devices market is moderately competitive, with leading manufacturers focusing on the development of high-performance, synthetic, and bio-based formulations to improve machinery efficiency and operational reliability. Companies are expanding their product portfolios with advanced hydraulic, process, and metalworking oils to enhance equipment life and reduce downtime. Moreover, strategic collaborations between lubricant producers, machinery manufacturers, and research institutions are driving innovation and enabling the introduction of region-specific and eco-friendly solutions, driving long-term competitiveness across manufacturing, automotive, energy, and industrial sectors worldwide.
Major companies operating in the cardiac monitoring and cardiac rhythm management devices industry include Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Biotronik SE & Co. KG, Nihon Kohden Corporation, Baxter International, Schiller AG, OSI Systems, Inc., AliveCor Inc., and MicroPort Scientific Corporation.
Key Players
- Abbott Laboratories
- AliveCor Inc.
- Baxter International
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- GE HealthCare Technologies Inc.
- Koninklijke Philips N.V.
- Medtronic plc
- MicroPort Scientific Corporation
- Nihon Kohden Corporation
- OSI Systems, Inc.
- Schiller AG
Industry Developments
- August 2025: Cardiosense’s CardioTag wearable heart monitor received FDA clearance. It is the first device to capture ECG, PPG, and SCG signals together, offering noninvasive insights into heart function and supporting AI-driven tools for heart failure management.
- March 2025: MicroPort CRM received CE Mark approval for its SmartView Connect App Mobile on Android. The app enables Bluetooth pacemakers, ICDs, and CRT-D devices to transmit data securely to clinics through patients’ smartphones, eliminating the need for a bedside monitor.
Cardiac Monitoring and Cardiac Rhythm Management Devices Market Segmentation
By Type Outlook (Revenue, USD Billion, 2020–2034)
- Cardiac Monitoring Device
- ECG
- Implantable Cardiac Monitors
- Holter Monitors
- Mobile Cardiac Telemetry
- Cardiac Rhythm Management Devices
- Defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- Single Chamber
- Dual Chamber
- External Defibrillator
- Manual External Defibrillator
- Automatic External Defibrillator
- Wearable Cardioverter Defibrillator Pacemakers
- Implantable Cardioverter Defibrillators (ICD)
- Pacemakers
- Conventional
- Leadless
- Defibrillators
By Procedure Outlook (Revenue, USD Billion, 2020–2034)
- Invasive
- Non-invasive
By Application Outlook (Revenue, USD Billion, 2020–2034)
- Arrhythmias
- Myocardial Infarction
- Heart Failure
- Other Applications
By End User Outlook (Revenue, USD Billion, 2020–2034)
- Hospitals & Clinics
- Ambulatory Surgery Centers
- Other End Users
By Regional Outlook (Revenue, USD Billion, 2020–2034)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Cardiac Monitoring and Cardiac Rhythm Management Devices Market Report Scope
|
Report Attributes |
Details |
|
Market Size in 2024 |
USD 21.76 Billion |
|
Market Size in 2025 |
USD 22.78 Billion |
|
Revenue Forecast by 2034 |
USD 34.90 Billion |
|
CAGR |
4.85% from 2025 to 2034 |
|
Base Year |
2024 |
|
Historical Data |
2020–2023 |
|
Forecast Period |
2025–2034 |
|
Quantitative Units |
Revenue in USD Billion and CAGR from 2025 to 2034 |
|
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Industry Trends |
|
Segments Covered |
|
|
Regional Scope |
|
|
Competitive Landscape |
|
|
Report Techniqueat |
|
|
Customization |
Report customization as per your requirements with respect to countries, regions, and segmentation. |
© 2025 Polaris Market Research and Consulting. All rights reserved
